友發集團(601686.SH):“友發轉債”的轉股價向下修正為6.73元/股
格隆匯9月15日丨友發集團(601686.SH)公佈,根據《募集説明書》的相關條款及公司2022年第二次臨時股東大會授權,綜合考慮上述價格和公司實際情況,公司董事會決定將“友發轉債”的轉股價格向下修正為6.73元/股,自本次董事會審議通過日的次一交易日起至2022年12月31日,如再次觸發“友發轉債”轉股價格向下修正條件,該期間公司董事會將不提出向下修正“友發轉債”轉股價格的方案。自2023年1月1日開始重新起算,若再次觸發“友發轉債”轉股價格向下修正條件,屆時公司董事會將再次召開會議決定是否行使“友發轉債”轉股價格向下修正權利。本次修正後的轉股價格自2022年9月21日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.